Role of Inflammation in Diabetic Retinopathy
Open accessThe DOI matches its Crossref record; 248 of the 249 references it cites were found in a registry or an index.
Abstract
Diabetic retinopathy is a common complication of diabetes and remains the leading cause of blindness among the working-age population. For decades, diabetic retinopathy was considered only a microvascular complication, but the retinal microvasculature is intimately associated with and governed by neurons and glia, which are affected even prior to clinically detectable vascular lesions. While progress has been made to improve the vascular alterations, there is still no treatment to counteract the early neuro-glial perturbations in diabetic retinopathy. Diabetes is a complex metabolic disorder, characterized by chronic hyperglycemia along with dyslipidemia, hypoinsulinemia and hypertension. Increasing evidence points to inflammation as one key player in diabetes-associated retinal perturbations, however, the exact underlying molecular mechanisms are not yet fully understood. Interlinked molecular pathways, such as oxidative stress, formation of advanced glycation end-products and increased expression of vascular endothelial growth factor have received a lot of attention as they all contribute to the inflammatory response. In the current review, we focus on the involvement of inflammation in the pathophysiology of diabetic retinopathy with special emphasis on the functional relationships between glial cells and neurons. Finally, we summarize recent advances using novel targets to inhibit inflammation in diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and this might explain the difference in rates of intraocular inflammation between eyes with diabetic retinopathy and those with AMD, despite being treated with the same vector and concentration.”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inflammatory processes are known to be integral in the pathogenesis of diabetic retinopathy,82”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rajamani, U., & Jialal, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/790902 · Cited by 114
RetractedInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Wh n ot resolved in a timely fashion the typically b nefici l eff ct of inflammation is lost a d dramatic consequence ensues [43].”
Background(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Reactive astrocytes: cellular and molecular cues to biological function
Ridet, J. L., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Research works printed but not linked: 1
- (2017, October 30). Allegro Ophthalmics Announces Positive Topline Results from Del Mar Phase 2b Trial Evaluating Luminate® in Patients with Diabetic Macular Edema. Available online: http://www.allegroeye.com/press.
Cited by
Items 701–749 of 749
Modèles cellulaires de l’inflammation dans le segment postérieur de l’œil
Raîche-Marcoux, G., Guérin, S. L., & Boisselier, É. (2025) · médecine/sciences · doi:10.1051/medsci/2025099
Dong, M., Cao, W.-Y., Deng, X.-X., Zhang, W.-X., Xing, Y.-Q., & Yang, N. (2025) · International Journal of Ophthalmology · doi:10.18240/ijo.2025.10.22
“Early leukocyte activation, triggered by metabolic disorders involving lipid and glucose metabolism, results in recurrent capillary occlusion and progressive retinal ischemia [5] .”
Noscapine Alleviates Hyperglycemia-triggered Retinal Microangiopathy in STZ-treated Rats
Wei, H., & Zheng, D. (2025) · Pharmacognosy Magazine · doi:10.1177/09731296251374434
“…activates various signaling pathways, and promotes epigenetic modifications, leading to inflammation in DR. Elevated levels of pro-inflammatory cytokines, including TNF-α, IL-1β, IL-6, and MCP-1, have been detected in the vitreous, serum, and retinal tissues of DR patients (Rubsam et al., 2018).”
Afandi, B. O., Attwan, A., Ponirakis, G., Malik, R. A., Alamoudi, R. M., Shaltout, I., Malik, R., Habib, M., Odhaib, S. A., Hussein, Z. B., et al. (2025) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0045-1812012
Recent advances in bioinspired polymeric nanofiber for the treatment of inflammatory diseases
Sahu, G., Maurya, M., Pandey, H., & Mishra, S. B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27745-0.00011-9
A case-control study of promoter and 5'UTR VEGF polymorphisms in diabetic retinopathy
Abu-Hassan, D. W., Bdour, M. D. A., Tahir, H., Freihat, M., Saleh, I., El-Khateeb, M. S., & Kelley, M. J. (2025) · Biomedical Papers · doi:10.5507/bp.2025.032
A New Paradigm in Understanding the Pathophysiological Mechanisms of Diabetic Retinopathy
Baskan, B. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1013026
Li, Z., Yuan, Y., Qi, Q., Wang, Q., & Feng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26612723
Li, Z., Yuan, Y., Qi, Q., Wang, Q., & Feng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26612711
Maghbooli, Z., Meimand, S. E., Malek Hosseini, A.-A., & Shirvani, A. (2022) · Figshare · doi:10.6084/m9.figshare.20219711
Li, Z., Yuan, Y., Qi, Q., Wang, Q., & Feng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26612717
Li, Z., Yuan, Y., Qi, Q., Wang, Q., & Feng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26612714
Li, Z., Yuan, Y., Qi, Q., Wang, Q., & Feng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26612708
Wang, H., Guo, Z., & Xu, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19766118
Niu, T., Shi, X., Liu, X., Wang, H., Liu, K., & Xu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25157317
Niu, T., Shi, X., Liu, X., Wang, H., Liu, K., & Xu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25157825
Li, Z., Yuan, Y., Qi, Q., Wang, Q., & Feng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26612720
Li, J., Hu, F., Lu, X., Shen, Y., Chen, J., & Zhang, H. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02129-2
“Pro-inflammatory cytokines play a crucial role in the development of DPN such as TNF-α, C-reactive protein, IL-1, IL-6, IL-8 and monocyte chemoat tractant protein-1 (MCP-1) [9, 24].”
Niu, D., Ye, L., Gu, X., Zhang, Y., Wang, F., Hui, Q., Xie, H., Liu, L., Li, X., Yan, X., et al. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02135-x
“Chronic hyperglycemia, oxidative stress, and inflammation are key drivers of retinal microvascular damage in diabetes [4, 5].”
Johansen, M. S., Stidsen, J. V., Hansen, A. L., Johansen, T. S. D., Nielsen, J. S., Pedersen, F. N., Grauslund, J., Olsen, M. H., Højlund, K., & Olesen, T. B. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113195
Wei, G., & Lu, Z. (2026) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-026-07195-3
Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema
Singer, M. A., Wykoff, C. C., Riemann, C. D., Gonzalez, V. H., Weng, C. Y., Alkhatib, K., Amarshi, R. A., Moody, S., & Pao, M. (2026) · Ophthalmology · doi:10.1016/j.ophtha.2026.03.019
Biomarkers in the assessment of diabetic retinopathy progression
Fayzrakhmanov, R. R., Pavlovskiy, O. A., Saraeva, S. N., & Martynov, A. O. (2026) · Russian Ophthalmological Journal · doi:10.21516/2072-0076-2026-19-1-203-209
Serdiuk, A. V. (2026) · Medical Science of Ukraine (MSU) · doi:10.32345/2664-4738.1.2026.04
Yerlikaya, E. I., Sunilkumar, S., SUBRAHMANIAN, S. M., Toro, A. L., Yeager, C. T., Shaikh, K. A., Harhaj, E. W., Barber, A. J., & Dennis, M. D. (2026) · Glia · doi:10.1002/glia.70155
“Increased production of pro-inflammatory factors contributes to the development and progression of DR (Rübsam et al. 2018).”
Advances in the Role of the CD40–CD154 Pathway in the Pathogenesis of Diabetic Retinopathy
Subauste, C. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093862
“This assertion is supported by the increased expression of various pro-inflammatory molecules in animals and patients with DR and the protective effects against DR induced by genetic or pharmacologic disruption of inflammatory mediators or the use of global anti-inflammatory agents in animals [2–4].”
Hamou, M. O., Masset, M., Weber, C., Scifo, L., Libert, S., Bryla, A., Grégoire, F., Delforge, V., Bolaky, N., Datlibagi, A., et al. (2025) · Molecular vision · doi:10.63500/mv_v31_380
“…recruited under the action of MCP-1 secrete various proangiogenic molecules, such as VEGF, and proinflammatory molecules, resulting in structural modification of the BRB and leukostasis in retinal capillaries, promoted in part by overproduction of intercellular adhesion molecule 1 [26,46,48,49].”
Zhang, Z., Shan, X., Liang, F.-M., & Zhang, L.-X. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i5.115813
Cuevas, B., Zubía, E., Martín-Loro, F., & Arroba, A. I. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18050606
“In this sense, accumulating evidence indicates that the inflammatory phenomena that occur during DR play a key role in the onset and progression of retinal pathology [34], and, therefore, decreasing early retinal inflammation could be a crucial contribution to DR management.”
Crónica legislativa de Navarra. Año 2025
Piñeiro, M. D. C. B. (2026) · Revista de llengua i dret · doi:10.58992/rld.i85.2026.4635
Zhang, Q., Li, H., Zhao, Y., Liu, X., Sun, Q., & Li, J. (2026) · Gene · doi:10.1016/j.gene.2026.150271
Luu, B., van Dijk, E. H. C., Hein, M., An, D., Yu, D., & Balaratnasingam, C. (2026) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2026.06.009 · Cited by 1
Prevalence of and risk factors for diabetic retinopathy: The Thessaloniki Eye Study
Keskini, C., Coleman, A. L., Harris, A., Wilson, M. R., Yu, F., Founti, P., Anastasopoulos, E., Haidich, A., Pappas, T., Panos, G. D., et al. (2026) · Eye · doi:10.1038/s41433-026-04698-5 · Cited by 1
“● Approximately one-third of individuals with self-reported diabetes had signs of DR, and more than 70% were unaware of their condition, highlighting a substantial gap in diagnosis and screening.”
Liu, J., Liu, W., Li, L., Zhang, Q., Zhang, J., & Yan, W. (2026) · Antioxidants · doi:10.3390/antiox15070865
“Activated microglia, reactive Müller glia, infiltrating leukocytes, and injured endothelial cells can, in turn, release additional reactive oxygen species and pro-inflammatory mediators, further exacerbating endothelial dysfunction, blood–retinal barrier disruption, and neuronal injury [6,14,45,46].”
Diabetic Retinopathy: From Molecular Mechanisms to Modern Therapy
Shebardina, N. G., Kazakova, K. A., Asaevich, T. A., Belolipskaya, S. A., Rodionov, I. V., Tulush, S. S., Shishkin, M. L., Komarov, A. R., Krasienko, O. A., Gromova, E. S., et al. (2026) · Biochemistry (Moscow) · doi:10.1134/s000629792660105x · Cited by 1
“Collectively, these processes lead to destabilization of cell–cell contacts, degradation of ECM components, and pericyte apoptosis, ultimately compromising BRB integrity [40, 48].”
The Investigation of Type 2 Diabetic Retinopathy in Conjunction with Dry Eye Disease: A Pilot Study
Aalam, W. A., Aidarous, S., Bahadur, R. Y., Alhutami, L., Minhas, M., Jambi, S., & Alhalwani, A. Y. (2026) · The Open Ophthalmology Journal · doi:10.2174/0118743641482180260722113915
Molecular and Cellular Crosstalk in the Pathogenesis of Diabetic Retinopathy
Sadikan, M. Z., & Nasir, N. A. A. (2026) · Archives of Medical Science · doi:10.5114/aoms/220653
“Inflammatory cytokines such as IL-1 β , IL-6, IL-8, TNF-α and MCP-1 have been reported to be elevated in ocular tissues from NPDR patients [180].”
InfluentialThe hard exudate pathway: Biological mechanisms, imaging correlates, and clinical implications
Venkatesh, R., Hande, P., Prabhu, V., Tendulkar, K., Chokkahalli, N. K., Jayadev, C., Yadav, N. K., Angrish, S., Sirsikar, A., & Chhablani, J. K. (2026) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2026.07.013
Investigating the Antidiabetic Effects of Calotropis procera : Preclinical Assessment
Kuo, Y., Ajibola, M. I., Lukman, H. Y., Lawal, B., Chen, L.-C., Huang, S., Ajayi, O. D., Onikanni, S. A., Sabiu, S., Miranda‐Alves, L., et al. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71364
LECT2–RPS27A interaction involving Lys48 attenuates neuroinflammation in diabetic retinopathy
Liu, Z., Yin, H., Zhu, K., Shao, L., Wang, Y., Yuan, Y., Zhang, J., Lin, S., Wang, Q., Jin, L., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06826-y
“Hyperglycaemia promotes glial activation and increases retinal levels of vascular endothelial growth factor (VEGF), TNF-α, IL-1β and IL-6 in individuals with diabetic retinopathy and in animal models [10–13].”
Guo, T., Liu, Y., He, M., Lian, Y., Wu, X., Zhao, H., Chen, X., Mo, Z., Li, Y., Chi, M., et al. (2026) · Current Eye Research · doi:10.1080/02713683.2026.2714720
Angers, S., Wykoff, C. C., Antonetti, D. A., Junge, H. J., Nudleman, E., Nagiel, A., Schlottmann, P. G., D’Amico, D. J., Prenner, J. L., Guyer, D. R., et al. (2026) · Ophthalmology and Therapy · doi:10.1007/s40123-026-01476-0 · Cited by 1
“However, a substantial proportion of patients fail to respond adequately to anti-VEGF therapy [35].”
InfluentialOliveira, S., Matafome, P., Bernardes, R., & Ambrósio, A. F. (2026) · Heliyon · doi:10.1016/j.heliyon.2026.e45290
Effects of Curcumin on Inflammation in a Rat Model of Diabetic Retinopathy
Yu, H. S., Kang, J. H., Kim, S. H., Cho, H., Koh, S., Hong, E. H., & Shin, Y. U. (2026) · Life · doi:10.3390/life16091427
“Hyperglycemia promotes oxidative stress, inflammatory signaling, vascular abnormalities, and glial responses in the retina [9].”
The roles of centrosome amplification in diabetes-associated diseases
Lee, S. C., Xu, P., & Wu, Q. G. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1877870
“In microvascular complications, cytokine-driven pericyte loss, blood-retinal barrier breakdown, VEGF upregulation, neovascularization, and neurodegeneration underlie retinopathy (Rubsam et al., 2018).”
Interferon-mediated regulation of the neurovascular unit in diabetic retinopathy
Yu, H., Xie, L., & Lin, W. (2026) · Inflammation Research · doi:10.1007/s00011-026-02369-5
“Microglia are involved in the clearance of myelin debris at sites of injury in DR [60 ].”
Kida, T., & Flammer, J. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111251
Multiscale Interactome Analysis Prioritizes Candidate Herbs and Compounds for Diabetic Retinopathy
Ahn, Y.-S., Chae, J.-I., Han, S.-K., Lee, W.-Y., & 박치현 (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209066
“The KEGG results highlighted the AGE–RAGE signaling pathway in diabetic complications, together with inflammatory axes such as the TNF and IL-17 signaling pathways and pathways of neurodegeneration— routes that are central to the microvascular and neuronal damage of diabetic retinopathy [33].”
Aydoğmuş, F. S. A., Kalaycı, D., Neşeli̇oğlu, S., Okyar, G., & Erel, Ö. (2026) · Diagnostics · doi:10.3390/diagnostics16213533
Metadata
- Authors
- Rübsam, A., Parikh, S., & Fort, P.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Fort, Patrice
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-03-22
- Volume
- 19
- Issue
- 4
- Pages
- 942
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5979417
- OpenAlex
- W2793401320
- Cited by
- 750
- References
- 249
- Citations by year
- 2026: 46 · 2025: 91 · 2024: 107 · 2023: 118 · 2022: 127 · 2021: 107 · 2020: 83 · 2019: 59 · 2018: 11
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Eye Institute (R01-EY020895)
- Deutsche Forschungsgemeinschaft (RU 2020/2-1)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- diabetic retinopathy, inflammation, neuroglial interactions, retinal microvasculature, oxidative stress, advanced glycation end products, vascular endothelial growth factor, glial cells, neurons, diabetes complications
- MeSH terms
- Animals, Astrocytes, Diabetic Retinopathy, Humans, Inflammation, Neurodegenerative Diseases, Ependymoglial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.